** Cancer therapy maker Legend Biotech's LEGN.O shares rise 5.6% to $35.96
** Co posts Q4 adj. net loss of 16 cents per share, compared to a loss of 24 cents per share a year earlier
** Cash and cash equivalents, and time deposits of $1.1 billion, as of December 31, 2024, which co believes will provide financial runway into Q2 2026
** LEGN has fallen 46.1% in the past 12 months
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments